China Gateway Biologics (CGB) was established in 2015, is a wholly-owned subsidiary of ChemPartner. CGB is mainly located in Zhangjiang High-tech Park, Shanghai, is also constructing its GMP manufacturing site in Qidong, Jiangsu to meet various requirements for clients.
CGB focus on biologics CMC development, pilot-scale preparation for IND and clinical trials. CGB can provide one-stop services for overall process development and IND application support, including cell line development and banking, cell culture development, purification development, formulation, aseptic filling & finish, druggability study, final container extractable and leachable and analytical development & testing. CGB has established complete quality system and strive to comply with ICH guidelines and the highest standards of CFDA, FDA and EMA.
CGB now is consist of senior experts having many year working experience from US and European big pharmas, as well as local scientists experienced in CDMO services. CGB aim to become the most trusted and reliable partner for customers on their way on new drug research and development.